Pancreatic cystic lesions: the challenge of risk stratification for malignancy

Endoscopy 2015; 47(06): 562
DOI: 10.1055/s-0034-1391394

Letters to the editor

Luca Barresi

,

Ilaria Tarantino

,

Dario Ligresti

,

Gabriele Curcio

,

Antonino Granata

,

Floriana Barbera

,

Loredana Bruno

,

Piergiulio Conaldi

,

Mario Traina

References
1 Al-Haddad MA, Kowalski T. Siddiqui A et al. Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts. Endoscopy 14.10.2014; DOI: DOI: 10.1055/s-0034-1390742. [Epub ahead of print].
2 Goh BK, Tan DM, Thng CH et al. Are the Sendai and Fukuoka consensus guidelines for cystic mucinous neoplasm of the pancreas useful in the initial triage of all suspected pancreatic cystic neoplasms? A single-institution experience with 317 surgically-treated patients. Ann Surg Oncol 2014; 21: 1919-1926
3 Tanaka M, Fernandez-del Castillo CC, Adsay V et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012; 12: 183-197
4 Khalid A, Zahid M, Finkelstein SD et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc 2009; 69: 1095-1102